|
2023
|
Invention
|
Antibody targeting crtam and pd-l1 and use thereof. The present invention relates to the field of... |
|
|
Invention
|
Anti-crtam/anti-pd-l1 antibody and use thereof. The present invention relates to the field of ant... |
|
|
Invention
|
Selective cdk12/13 inhibitor and application thereof. The present invention belongs to the field ... |
|
|
Invention
|
Compound serving as eif4e inhibitor and use thereof. The present invention relates to the field o... |
|
|
Invention
|
Gspt1 degradation agent and use thereof. The present invention belongs to the field of medicinal ... |
|
2022
|
Invention
|
Anti-crtam antibody and application thereof. The present invention provides an anti-CRTAM antibod... |
|
|
Invention
|
Anti-ctla-4 antibody and use thereof. The present invention relates to the technical field of ant... |
|
2021
|
Invention
|
Macrocyclic heterocyclic compounds as egfr inhibitors, and use thereof. The present invention rel... |
|
|
Invention
|
Anti-tigit antibody and double antibody and their application.
The present invention relates to ... |
|
|
Invention
|
Anti-tigit antibody and double antibody and their application. The present invention relates to t... |
|
|
Invention
|
Anti-cd47/anti-pd-l1 antibody and applications thereof.
Provided are an anti-CD47/anti-PD-L1 ant... |
|
|
Invention
|
Anti-cd47/anti-pd-l1 antibody and applications thereof. Provided are an anti-CD47/anti-PD-L1 anti... |
|
2020
|
Invention
|
Compound as shp2 inhibitor and use thereof.
The present invention falls within the field of medi... |
|
|
Invention
|
Compound as shp2 inhibitor and use thereof. The present invention falls within the field of medic... |
|
|
Invention
|
Substituted tricyclic compound as prmt5 inhibitor and use thereof.
The present invention belongs... |
|
|
Invention
|
Substituted tricyclic compound as prmt5 inhibitor and use thereof. The present invention belongs ... |
|
|
Invention
|
Anti-b7-h3 antibody and application thereof.
Provided is an anti-B7-H3 antibody or antigen-bindi... |
|
|
Invention
|
Anti-b7-h3 antibody and application thereof. Provided is an anti-B7-H3 antibody or antigen-bindin... |
|
2019
|
Invention
|
Tgf-βr1 inhibitor and use thereof. The present invention belongs to the field of medicinal chemis... |
|
|
Invention
|
Monobactam compounds and use therefor.
Monobactam compounds and a use therefor. Specifically pro... |
|
|
Invention
|
Monobactam compounds and use therefor. Monobactam compounds and a use therefor. Specifically prov... |
|
|
Invention
|
1,3,4-oxadiazole-2-cyclobutyl compounds, preparation method therefor and application thereof. The... |
|
|
Invention
|
Compound as tgf-beta r1 inhibitor and application thereof.
The present application relates to a ... |
|
|
Invention
|
Compound as tgf-β r1 inhibitor and application thereof. The present application relates to a comp... |
|
|
Invention
|
Anti-cd47 antibody and application thereof. The present disclosure relates to the technical field... |
|
|
Invention
|
Anti-cd47 antibody and application thereof. The present invention relates to the technical field ... |
|
|
Invention
|
Anti-claudin18.2 antibody and use thereof.
Provided are an anti-Claudin18.2 antibody or an antig... |
|
|
Invention
|
Anti-claudin18.2 antibody and use thereof. Provided are an anti-Claudin18.2 antibody or an antige... |
|
2018
|
Invention
|
Compound as acc inhibitor and use thereof. Disclosed are a class of compounds which are inhibitor... |
|
|
Invention
|
Heterocyclic compound acting as ask inhibitor and use thereof. The present invention belongs to t... |
|
|
Invention
|
Fgfr4 inhibitor and preparation and use thereof. The present invention falls within the field of ... |
|
|
Invention
|
Heterocyclic compound serving as pd-l1 inhibitor. The present invention relates to the field of m... |
|
|
Invention
|
Pentacyclic compound as selective estrogen receptor down-regulator and use thereof. The present i... |
|
|
Invention
|
Tricyclic compound as selective estrogen receptor down-regulator and use thereof. The present inv... |
|
2017
|
Invention
|
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor. Disclosed is a fused-r... |
|
|
Invention
|
Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof. Provided are a ... |
|
2016
|
Invention
|
New epidermal growth factor receptor inhibitor and application thereof. An epidermal growth facto... |
|
|
Invention
|
Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereof... |
|
|
Invention
|
Substituted pyrimidine compounds as phosphatidylinositol 3-kinase δ inhibitor and use thereof. Th... |
|
2015
|
Invention
|
Hepatitis c virus inhibitor and application thereof. The present invention relates to the field o... |
|
|
Invention
|
Phenyl-substituted triazine compound serving as egfr inhibitor and applications thereof. The pres... |
|
2014
|
Invention
|
9,9,10,10-tetrafluoro-9,10-dihydrophenanthrene hepatitis c virus inhibitor and application thereo... |
|
|
Invention
|
Hepatitis c virus inhibitor and uses thereof. The present invention belongs to the chemical and p... |
|
|
Invention
|
Bcr-abl kinase inhibitor and application thereof. The present invention relates to the field of c... |
|
|
Invention
|
Nucleoside phosphoramidate compound and use thereof. A novel nucleoside phosphoramidate compound ... |
|
2013
|
Invention
|
Heteroaryl alkyne compound and use thereof. In the field of pharmaceutical chemistry compounds of... |
|
|
Invention
|
Alkynyl heteroaromatic compound and use thereof.
The present invention belongs to the field of p... |
|
|
P/S
|
medicinal preparations for humans, namely, [ antibiotic medicines, cardiovascular drugs, ] digest... |
|
|
P/S
|
Human medicine. |
